Intrinsic Value of S&P & Nasdaq Contact Us

Seagen Inc. SGEN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$171.82
-24.9%

Financial Health Score — SGEN

Seagen Inc. (SGEN) has an overall financial health rating of B with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-12-22.

B
Overall Rating
2023-12-22

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2023-12-22 B -/5 -/5 -/5 -/5 -/5 -/5
2023-12-18 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-13 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-12 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-11 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-08 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-07 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-06 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-05 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-04 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-01 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-11-30 B+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message